Znanstveni rad - Izvorni znanstveni rad
Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab
Journal of Neuroimmunology, 362 (2022); 577788. https://doi.org/10.1016/j.jneuroim.2021.577788

Adamec, Ivan; Rogić, Dunja; Penz, Monika-Gabriele; Braun, Carola; Habek, Mario

Povezani objekti
COVID-19 | Virtualna zbirka
Citirajte ovaj rad

Adamec, I., Rogić, D., Penz, M. G., Braun, C. i Habek, M. (2022). Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab. Journal of Neuroimmunology, 362.. doi: 10.1016/j.jneuroim.2021.577788

Adamec, Ivan, et al. "Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab." Journal of Neuroimmunology, vol. 362, 2022. https://doi.org/10.1016/j.jneuroim.2021.577788

Adamec, Ivan, Dunja Rogić, Monika Gabriele Penz, Carola Braun i Mario Habek. "Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab." Journal of Neuroimmunology 362 (2022). https://doi.org/10.1016/j.jneuroim.2021.577788

Adamec, I., et al. (2022) 'Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab', Journal of Neuroimmunology, 362. doi: 10.1016/j.jneuroim.2021.577788

Adamec I, Rogić D, Penz MG, Braun C, Habek M. Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab. Journal of Neuroimmunology [Internet]. 15.01.2022. [pristupljeno 24.09.2022.];362. doi: 10.1016/j.jneuroim.2021.577788

I. Adamec, D. Rogić, M. G. Penz, C. Braun i M. Habek, "Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab", Journal of Neuroimmunology, vol. 362, Siječanj 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:570068. [Citirano: 24.09.2022.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.